Pain Management in CKD: Reduce Exposure, Preserve Function

Student Handouts and Nephrology Primer · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Treat the pain mechanism while checking predictable kidney, bleeding, sedation, and fall risks.

What limits function, and which option fits the kidneys?. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

What limits function, and which option fits the kidneys?. Physical and local options — Match treatment to pain mechanism and goals; Systemic medicines — Assess clearance, interactions and nephrotoxicity; Sedation and falls — Review adverse effects and actual function. Use a concrete follow-up measure and a medicine-specific safety plan. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Define what limits function

Distinguish focal musculoskeletal pain, neuropathic pain, acute injury, and systemic illness. Set a measurable goal such as walking or sleep. Unexplained fever, weakness, trauma, or progressive neurologic signs changes the evaluation.

Identify the NSAID risk combination

Systemic NSAIDs constrict the afferent arteriolar response. Dehydration, diuretics, and ACE inhibitor/ARB therapy increase susceptibility to AKI. Ask specifically about over-the-counter ibuprofen or naproxen.

Use local options for a local problem

Exercise modification, rehabilitation, and selected topical treatments can reduce systemic drug exposure. A topical NSAID still needs labeled use and intact skin; topical lidocaine fits certain localized neuropathic syndromes, not every pain mechanism.

Check accumulation and sedation

Gabapentin/pregabalin and several opioid metabolites require kidney-function-aware prescribing. New somnolence, confusion, myoclonus, or falls warrants medication review; do not simply increase the dose for persistent pain.

A concrete follow-up check

After a pain-plan change, assess function, adverse effects, new edema, blood pressure, and any indicated kidney/electrolyte testing. Ask whether multiple combination products duplicate the same analgesic.

Worked example

A patient on a diuretic and ARB develops diarrhea, then adds ibuprofen for back pain. Address volume loss and medication-related AKI risk with the treating clinician; substituting a generic “pain bundle” does not solve the interaction.

Continue learning